A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells-Reference-Cited by-同舟云学术

A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells

Published:2008-04-18 Issue:9 Volume:15 Page:563-575
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Poulsen T T,Pedersen N,Juel H,Poulsen H S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt200824.pdf

Reference47 articles.

1. Ciombor KK, Rocha Lima CM . Management of small cell lung cancer. Curr Treat Options Oncol 2006; 7: 59–68.

2. Poulsen TT, Pedersen N, Poulsen HS . Replacement and suicide gene therapy for targeted treatment of lung cancer. Clin Lung Cancer 2005; 6: 227–236.

3. Moolten FL . Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276–5281.

4. Fillat C, Carrio M, Cascante A, Sangro B . Suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene/ganciclovir system: fifteen years of application. Curr Gene Ther 2003; 3: 13–26.

5. Tanaka M, Inase N, Miyake S, Yoshizawa Y . Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma. Anticancer Res 2001; 21: 291–294.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacological and biological importance of EZH2 signaling in lung cancer;Biomedicine & Pharmacotherapy;2023-04

2. Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes;Cells;2021-06-18

3. EZH2 Expression in Intestinal Neuroendocrine Tumors;Applied Immunohistochemistry & Molecular Morphology;2019-10

4. A Universal Tumor-Specific Promoter for Cancer Gene Therapy;Doklady Biochemistry and Biophysics;2018-05

5. Therapeutic Improvement of a Stroma-Targeted CRAd by Incorporating Motives Responsive to the Melanoma Microenvironment;Journal of Investigative Dermatology;2013-11